Skip to main content
Erschienen in: Supportive Care in Cancer 10/2007

01.10.2007 | Original Article

Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer

verfasst von: Cyril Danjoux, Sandra Gardner, Margaret Fitch

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To prospectively evaluate radiation-induced fatigue among patients undergoing curative radiotherapy at the Toronto Sunnybrook Regional Cancer Centre using two different instruments.

Materials and methods

Consecutive consenting English speaking men receiving curative radiotherapy for localised prostate cancer were enrolled in a prospective ethics board approved study. We used an 11 questions fatigue questionnaire (FQ) based on a modified FACT-AN questionnaire and the 2 questions of the fatigue pictogram (FP) to record patients’ responses weekly during treatment. The 11 FQ items were summed to calculate a fatigue scale (FS). The proportion and 95% confidence interval for each FQ and FP item and mean FS was calculated at baseline, week 3 and week 6. Chi-squared tests or analysis of variance f-tests were used to compare treatment groups and paired t-tests to compare baseline to week 6. A linear mixed model was used to compare the mean FS for treatment groups across time.

Results

From June 2000 to June 2003, we enrolled 130 patients. Fifty-one received conformal radiotherapy to the prostate (CRT), 46 received whole pelvis and prostate boost radiotherapy (WP+PB) and 33 received post prostatectomy radiotherapy to the prostate bed (PBRT). At baseline, 39% (30–47%) reported some fatigue for the FQ and 60% (52–68%) for the FP tiredness item. As treatment progressed, the mean fatigue increased significantly. The FP tiredness item best differentiated between treatment groups (p = 0.04 at week 6) compared to the FQ tiredness item or FS. Those receiving irradiation to smaller volumes (CRT or PBRT) reported lower FS scores than those treated to larger volumes (WP+PB) across time.

Conclusions

The pictogram was better than the questionnaire in differentiating between treatment groups. The pictogram could be used to screen and monitor patients with baseline fatigue for interventional studies in a busy clinic.
Literatur
1.
Zurück zum Zitat Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4–12PubMed Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 34(3 Suppl 2):4–12PubMed
2.
Zurück zum Zitat Akechi T, Kugaya A, Okamura H, Yamawaki S, Uchitomi Y (1999) Fatigue and its associated factors in ambulatory cancer patients: a preliminary study. J Pain Symptom Manage 17(1):42–48PubMedCrossRef Akechi T, Kugaya A, Okamura H, Yamawaki S, Uchitomi Y (1999) Fatigue and its associated factors in ambulatory cancer patients: a preliminary study. J Pain Symptom Manage 17(1):42–48PubMedCrossRef
3.
Zurück zum Zitat Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W (1998) Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 12(11A):369–377 Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W (1998) Progress toward guidelines for the management of fatigue. Oncology (Williston Park) 12(11A):369–377
4.
Zurück zum Zitat Lilleby W, Fossa SD, Waehre HR, Olsen DR (1999) Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 43(4):735–743PubMedCrossRef Lilleby W, Fossa SD, Waehre HR, Olsen DR (1999) Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 43(4):735–743PubMedCrossRef
5.
Zurück zum Zitat Janda M, Gerstner N, Obermair A, Fuerst A, Wachter S, Dieckmann K, Potter R (2000) Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 89(6):1322–1328PubMedCrossRef Janda M, Gerstner N, Obermair A, Fuerst A, Wachter S, Dieckmann K, Potter R (2000) Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 89(6):1322–1328PubMedCrossRef
6.
Zurück zum Zitat Stone P, Richards M, A’Hern R, Hardy J (2001) Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage 22(6):1007–1015PubMedCrossRef Stone P, Richards M, A’Hern R, Hardy J (2001) Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage 22(6):1007–1015PubMedCrossRef
7.
Zurück zum Zitat Monga U, Kerrigan AJ, Thornby J, Monga TN (1999) Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig 7(3):178–185PubMedCrossRef Monga U, Kerrigan AJ, Thornby J, Monga TN (1999) Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig 7(3):178–185PubMedCrossRef
8.
Zurück zum Zitat Monga U, Kerrigan AJ, Thornby J, Monga TN, Zimmermann KP (2005) Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy. J Rehabil Res Dev 42(3):391–399PubMedCrossRef Monga U, Kerrigan AJ, Thornby J, Monga TN, Zimmermann KP (2005) Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy. J Rehabil Res Dev 42(3):391–399PubMedCrossRef
9.
Zurück zum Zitat Truong PT, Berthelet E, Lee JC, Petersen R, Lim JTW, Gaul CA, Pai H, Blood P, Ludgate CM (2006) Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy. Can J Urol 13(3):3139–3146PubMed Truong PT, Berthelet E, Lee JC, Petersen R, Lim JTW, Gaul CA, Pai H, Blood P, Ludgate CM (2006) Prospective evaluation of the prevalence and severity of fatigue in patients with prostate cancer undergoing radical external beam radiotherapy and neoadjuvant hormone therapy. Can J Urol 13(3):3139–3146PubMed
11.
Zurück zum Zitat Lukka H, Warde P, Pickles T, Morton G, Brundage M, Souhami L; Canadian GU Radiation Oncologist Group (2001) Controversies in prostate cancer radiotherapy: consensus development. Can J Urol 8(4):1314–1322PubMed Lukka H, Warde P, Pickles T, Morton G, Brundage M, Souhami L; Canadian GU Radiation Oncologist Group (2001) Controversies in prostate cancer radiotherapy: consensus development. Can J Urol 8(4):1314–1322PubMed
12.
Zurück zum Zitat Lukka H (2002) Prostate cancer: risk categories and role of hormones and radiotherapy. Can J Urol 9(Suppl 1):26–29PubMed Lukka H (2002) Prostate cancer: risk categories and role of hormones and radiotherapy. Can J Urol 9(Suppl 1):26–29PubMed
13.
Zurück zum Zitat Smets EM, Garssen B, Bonke B, De Haes JC (1995) The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315–325PubMedCrossRef Smets EM, Garssen B, Bonke B, De Haes JC (1995) The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315–325PubMedCrossRef
14.
Zurück zum Zitat Glaus A (1998) Fatigue in patients with cancer. Analysis and assessment. Recent Results Cancer Res 145(I–XI):1–172 Glaus A (1998) Fatigue in patients with cancer. Analysis and assessment. Recent Results Cancer Res 145(I–XI):1–172
15.
Zurück zum Zitat Cella D (1997) The functional assessment of cancer therapy-anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl):13–19PubMed Cella D (1997) The functional assessment of cancer therapy-anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl):13–19PubMed
16.
Zurück zum Zitat Schwartz AL (1998) The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum 5(4):711–717 Schwartz AL (1998) The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum 5(4):711–717
17.
Zurück zum Zitat Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMed Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM (1998) The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 25(4):677–684PubMed
18.
Zurück zum Zitat Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP (1993) Development of fatigue scale. J Psychosom Res 37(2):147–153PubMedCrossRef Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP (1993) Development of fatigue scale. J Psychosom Res 37(2):147–153PubMedCrossRef
19.
Zurück zum Zitat Glaus A (1993) Assessment of fatigue in cancer and non-cancer patients and in healthy individuals. Support Care Cancer 1(6):285–286CrossRef Glaus A (1993) Assessment of fatigue in cancer and non-cancer patients and in healthy individuals. Support Care Cancer 1(6):285–286CrossRef
20.
Zurück zum Zitat Fitch MI, Bunston T, Mings D, Sevean P, Bakker D (2003) Evaluating a new clinical assessment tool: the fatigue pictogram. Support Care Cancer 11(6):403 Fitch MI, Bunston T, Mings D, Sevean P, Bakker D (2003) Evaluating a new clinical assessment tool: the fatigue pictogram. Support Care Cancer 11(6):403
21.
Zurück zum Zitat Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13(2):63–74PubMedCrossRef Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13(2):63–74PubMedCrossRef
22.
Zurück zum Zitat Hickok JT, Roscoe JA, Morrow GR, Mustian K, Okunieff P, Bole CW (2005) Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 104(8):1772–1778PubMedCrossRef Hickok JT, Roscoe JA, Morrow GR, Mustian K, Okunieff P, Bole CW (2005) Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 104(8):1772–1778PubMedCrossRef
23.
Zurück zum Zitat Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L (1994) The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17(5):367–378PubMedCrossRef Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L (1994) The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs 17(5):367–378PubMedCrossRef
24.
Zurück zum Zitat Monga U, Kerrigan AJ, Thornby J, Monga TN (1999) Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig 7(3):178–185PubMedCrossRef Monga U, Kerrigan AJ, Thornby J, Monga TN (1999) Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig 7(3):178–185PubMedCrossRef
25.
Zurück zum Zitat Greenberg DB, Sawicka J, Eisenthal S, Ross D (1992) Fatigue syndrome due to localized radiation. J Pain Symptom Manage 7(1):38–45PubMedCrossRef Greenberg DB, Sawicka J, Eisenthal S, Ross D (1992) Fatigue syndrome due to localized radiation. J Pain Symptom Manage 7(1):38–45PubMedCrossRef
26.
Zurück zum Zitat King KB, Nail LM, Kreamer K, Strohl RA, Johnson JE (1985) Patients’ descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum 12(4):55–61PubMed King KB, Nail LM, Kreamer K, Strohl RA, Johnson JE (1985) Patients’ descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum 12(4):55–61PubMed
27.
Zurück zum Zitat Rodrigues G, Bezjak A, Osoba D, Catton P, Tsuji D, Taylor D, Warde P (2004) The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer. Qual Life Res 13(7):1235–1246PubMedCrossRef Rodrigues G, Bezjak A, Osoba D, Catton P, Tsuji D, Taylor D, Warde P (2004) The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer. Qual Life Res 13(7):1235–1246PubMedCrossRef
28.
Zurück zum Zitat Fitch MI, Bunston T, Mings D (2001) The fatigue pictogram: a new clinical assessment tool. 6th Oncology Nursing Research Conference, Florida, February Fitch MI, Bunston T, Mings D (2001) The fatigue pictogram: a new clinical assessment tool. 6th Oncology Nursing Research Conference, Florida, February
29.
Zurück zum Zitat Fitch MI Bunston T, Sevean P, Bakker D (2003) Evaluating a new clinical assessment tool: the fatigue pictogram. 15th International Conference of the Multinational Association of Supportive Care in Cancer, Berlin, June Fitch MI Bunston T, Sevean P, Bakker D (2003) Evaluating a new clinical assessment tool: the fatigue pictogram. 15th International Conference of the Multinational Association of Supportive Care in Cancer, Berlin, June
Metadaten
Titel
Prospective evaluation of fatigue during a course of curative radiotherapy for localised prostate cancer
verfasst von
Cyril Danjoux
Sandra Gardner
Margaret Fitch
Publikationsdatum
01.10.2007
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2007
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0229-8

Weitere Artikel der Ausgabe 10/2007

Supportive Care in Cancer 10/2007 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.